Tech Company Financing Transactions
DermAvance Pharmaceuticals Funding Round
Commission Junction participated in a $300 thousand funding round for DermAvance Pharmaceuticals. The round was recorded on 6/30/2006.
Transaction Overview
Company Name
Announced On
6/30/2006
Transaction Type
Venture Equity
Amount
$300,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
274 West Lancaster Ave. 200
Malvern, PA 19355
USA
Malvern, PA 19355
USA
Phone
Website
Email Address
Overview
DermAvance Pharmaceuticals, a privately held pharmaceutical company specializing in advanced technology applications for skin health and cosmetic dermatology.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Keith Greathouse
VP - Bus. Development
John LaRosa
Browse more venture capital transactions:
Prev: 6/30/2006: Stylehive venture capital transaction
Next: 6/30/2006: Glimmerglass Networks venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs